$AMLX
Price history, market instrument context, member research, and related headlines in one place.
AMLX key statistics
NasdaqGSUSD
52-week range
$10.8353%$41.14
Latest session $26.46–$27.77Amylyx Pharmaceuticals, Inc. (AMLX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $27.03, up $0.18 (0.67%) from the previous close of $26.85. It has traded between $26.46 and $27.77 in the latest session. Over the past year it has ranged from $10.83 to $41.14, leaving it around the middle of its 52-week range (53%). Reported volume for the session was 1.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Amylyx Pharmaceuticals (AMLX) announced the pricing of an upsized underwritten public offering of 14.09M shares of common stock at $35.50 per share. The company also granted underwriters a 30-day option to buy up to an additional 2.11M shares.
Amylyx prices $500M stock offering at $35.50 per share — See source for full details.
Amylyx makes $350M public stock offering in wake of avexitide results — See source for full details.
Why is Amylyx Pharmaceuticals stock surging today? — See source for full details.
Amylyx succeeds in late-stage trial for GLP-1 drug — See source for full details.
Why is Amylyx Pharmaceuticals stock surging today? — See source for full details.
Amylyx stock rises on Phase 3 trial results date — See source for full details.
Amylyx surges on upcoming release of avexitide data — See source for full details.
Amylyx to announce phase 3 trial results for hypoglycemia drug — See source for full details.
Loading $AMLX research…